Recent Updates
Recently added Catalysts
RADX Positive Sentiment Score: 70/100

Radiopharm Ventures institutional & VC presentation

Monday, April 22, 2024 1 min read
Key Takeaway: Radiopharm Ventures has announced significant progress in its clinical studies, including the initiation of a Phase 1/2a study for BetaBart (RV-01) and receiving IND approval from the US FDA. The company has also provided positive updates across four of its programs, indicating a strong pipeline for future developments.

Market Sentiment Analysis

POSITIVE FACTORS

  • Radiopharm Theranostics has initiated a Phase 1/2a clinical study.
  • The company received IND approval from the US FDA for Betabart (RV-01).
  • Positive clinical updates have been shared across four programs.

Full Press Release Details

• Announcements
• April 22, 2024
Loading Viewer…

More Announcements & Updates

• Announcements
• December 15, 2023
• Announcements
• June 15, 2022
• Announcements
• July 31, 2024
• Announcements
• August 14, 2024

Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)

Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

CLINICAL UPDATE AND CAPITAL RAISING OCTOBER 20th, 2025

Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)

Dr. Oliver Sartor Appointed to Radiopharm Scientific Advisory Board

• RAD Presentation June 2026
• Zacks Small-Cap Research 2026
• RAD Presentation March 2026
• Radiopharm Theranostics Doses First Patient in Phase 1/2a ClinicalStudy of BetaBart (RV-01)
• Zacks SCR Analysts Share Their Best Small-Cap Research Ideas for 2026
• Zacks Small-Cap Research

Frequently Asked Questions

What clinical study has Radiopharm initiated?

Radiopharm has initiated a Phase 1/2a clinical study for BetaBart (RV-01).

What approval did Radiopharm receive from the FDA?

Radiopharm received IND approval from the US FDA to initiate its Phase I study for BetaBart.

How many programs received positive updates?

Radiopharm provided positive updates across four of its clinical programs.

Tags: RADX Viatris Investor Conferences Healthcare Radiopharm Theranostics BetaBart Phase 1/2a FDA approval clinical study
Last updated: Apr 22, 2024